Bremer Trust National Association’s GSK GSK Stock Holding History

Bremer Trust National Association’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$276K	Sell	5,794 -1,431	-20%	-$70.5K	0.06%	213
2018 Q3	$363K	Buy	7,225 +279	+4%	+$14.2K	0.09%	188
2018 Q2	$350K	Sell	6,946 -720	-9%	-$36.3K	0.1%	192
2018 Q1	$374K	Buy	7,666 +1,055	+16%	+$49.1K	0.11%	164
2017 Q4	$294K	Buy	6,611 +284	+4%	+$13.1K	0.08%	195
2017 Q3	$322K	Buy	6,327 +25	+0.4%	+$1.27K	0.09%	186
2017 Q2	$340K	Sell	6,302 -389	-6%	-$20.7K	0.1%	179
2017 Q1	$353K	Sell	6,691 -755	-10%	-$38.3K	0.1%	190
2016 Q4	$359K	Sell	7,446 -1,743	-19%	-$86.1K	0.1%	190
2016 Q3	$495K	Buy	9,189 +451	+5%	+$24.7K	0.13%	162
2016 Q2	$473K	Buy	8,738 +832	+11%	+$43.8K	0.13%	150
2016 Q1	$400K	Buy	7,906 +712	+10%	+$35.5K	0.12%	158
2015 Q4	$363K	Buy	7,194 +1,730	+32%	+$88.2K	0.11%	159
2015 Q3	$262K	Sell	5,464 -2,920	-35%	-$152K	0.09%	194
2015 Q2	$436K	Sell	8,384 -87	-1%	-$4.9K	0.13%	152
2015 Q1	$488K	Sell	8,471 -1,367	-14%	-$78.4K	0.16%	130
2014 Q4	$525K	Buy	9,838 +444	+5%	+$24.8K	0.17%	129
2014 Q3	$540K	Sell	9,394 -226	-2%	-$13.9K	0.18%	121
2014 Q2	$643K	Buy	9,620 +369	+4%	+$25K	0.23%	106
2014 Q1	$617K	Sell	9,251 -194	-2%	-$13.1K	0.23%	107
2013 Q4	$630K	Sell	9,445 -35	-0.4%	-$2.27K	0.24%	102
2013 Q3	$594K	Sell	9,480 -583	-6%	-$37.5K	0.25%	96
2013 Q2	$629K	Buy	+10,063	New	+$639K	0.28%	82

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bremer Trust National Association's GSK Position: Q4 2018 in Review

Bremer Trust National Association reduced its GSK (GSK) stake by 20% in Q4 2018, selling an estimated $70.5K and leaving 5,794 shares worth $276K. The position accounts for 0.06% of the portfolio, ranked #213.

Bremer Trust National Association first reported a position in GSK in Q2 2013 and has held it in 23 quarters since. The position peaked at $643K in Q2 2014. 800 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Bremer Trust National Association held 5,794 shares of GSK worth $276K as of Q4 2018.
Bremer Trust National Association sold 1,431 GSK shares in Q4 2018, an estimated $70.5K.
GSK made up 0.06% of Bremer Trust National Association's portfolio in Q4 2018, its #213 holding.
Bremer Trust National Association first reported a position in GSK in Q2 2013 and has held it in 23 quarters since.
Bremer Trust National Association's GSK position peaked at $643K in Q2 2014.
800 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.